684 related articles for article (PubMed ID: 21646721)
1. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.
Rayner KJ; Sheedy FJ; Esau CC; Hussain FN; Temel RE; Parathath S; van Gils JM; Rayner AJ; Chang AN; Suarez Y; Fernandez-Hernando C; Fisher EA; Moore KJ
J Clin Invest; 2011 Jul; 121(7):2921-31. PubMed ID: 21646721
[TBL] [Abstract][Full Text] [Related]
2. miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice.
Distel E; Barrett TJ; Chung K; Girgis NM; Parathath S; Essau CC; Murphy AJ; Moore KJ; Fisher EA
Circ Res; 2014 Oct; 115(9):759-69. PubMed ID: 25201910
[TBL] [Abstract][Full Text] [Related]
3. microRNAs in lipoprotein metabolism and cardiometabolic disorders.
Rotllan N; Price N; Pati P; Goedeke L; Fernández-Hernando C
Atherosclerosis; 2016 Mar; 246():352-60. PubMed ID: 26828754
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis.
Shen L; Peng H; Peng R; Fan Q; Zhao S; Xu D; Morisseau C; Chiamvimonvat N; Hammock BD
Atherosclerosis; 2015 Apr; 239(2):557-65. PubMed ID: 25733327
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1.
Lv YC; Tang YY; Peng J; Zhao GJ; Yang J; Yao F; Ouyang XP; He PP; Xie W; Tan YL; Zhang M; Liu D; Tang DP; Cayabyab FS; Zheng XL; Zhang DW; Tian GP; Tang CK
Atherosclerosis; 2014 Sep; 236(1):215-26. PubMed ID: 25084135
[TBL] [Abstract][Full Text] [Related]
7. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis.
Joyce CW; Wagner EM; Basso F; Amar MJ; Freeman LA; Shamburek RD; Knapper CL; Syed J; Wu J; Vaisman BL; Fruchart-Najib J; Billings EM; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB
J Biol Chem; 2006 Nov; 281(44):33053-65. PubMed ID: 16928680
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.
Rayner KJ; Esau CC; Hussain FN; McDaniel AL; Marshall SM; van Gils JM; Ray TD; Sheedy FJ; Goedeke L; Liu X; Khatsenko OG; Kaimal V; Lees CJ; Fernandez-Hernando C; Fisher EA; Temel RE; Moore KJ
Nature; 2011 Oct; 478(7369):404-7. PubMed ID: 22012398
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice.
Horie T; Baba O; Kuwabara Y; Chujo Y; Watanabe S; Kinoshita M; Horiguchi M; Nakamura T; Chonabayashi K; Hishizawa M; Hasegawa K; Kume N; Yokode M; Kita T; Kimura T; Ono K
J Am Heart Assoc; 2012 Dec; 1(6):e003376. PubMed ID: 23316322
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-20a/b regulates cholesterol efflux through post-transcriptional repression of ATP-binding cassette transporter A1.
Liang B; Wang X; Song X; Bai R; Yang H; Yang Z; Xiao C; Bian Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):929-938. PubMed ID: 28602962
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor.
de Aguiar Vallim TQ; Tarling EJ; Kim T; Civelek M; Baldán Á; Esau C; Edwards PA
Circ Res; 2013 Jun; 112(12):1602-12. PubMed ID: 23519696
[TBL] [Abstract][Full Text] [Related]
12. Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1.
Lv YC; Yang J; Yao F; Xie W; Tang YY; Ouyang XP; He PP; Tan YL; Li L; Zhang M; Liu D; Cayabyab FS; Zheng XL; Tang CK
Atherosclerosis; 2015 May; 240(1):80-9. PubMed ID: 25765596
[TBL] [Abstract][Full Text] [Related]
13. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.
Niesor EJ; Schwartz GG; Perez A; Stauffer A; Durrwell A; Bucklar-Suchankova G; Benghozi R; Abt M; Kallend D
Cardiovasc Drugs Ther; 2015 Feb; 29(1):7-14. PubMed ID: 25749868
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis.
Brunham LR; Singaraja RR; Duong M; Timmins JM; Fievet C; Bissada N; Kang MH; Samra A; Fruchart JC; McManus B; Staels B; Parks JS; Hayden MR
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):548-54. PubMed ID: 19201688
[TBL] [Abstract][Full Text] [Related]
16. microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis.
Ouimet M; Ediriweera H; Afonso MS; Ramkhelawon B; Singaravelu R; Liao X; Bandler RC; Rahman K; Fisher EA; Rayner KJ; Pezacki JP; Tabas I; Moore KJ
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1058-1067. PubMed ID: 28428217
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport.
Yamamoto S; Tanigawa H; Li X; Komaru Y; Billheimer JT; Rader DJ
Circulation; 2011 Sep; 124(12):1382-90. PubMed ID: 21859969
[TBL] [Abstract][Full Text] [Related]
18. Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis.
Karunakaran D; Thrush AB; Nguyen MA; Richards L; Geoffrion M; Singaravelu R; Ramphos E; Shangari P; Ouimet M; Pezacki JP; Moore KJ; Perisic L; Maegdefessel L; Hedin U; Harper ME; Rayner KJ
Circ Res; 2015 Jul; 117(3):266-78. PubMed ID: 26002865
[TBL] [Abstract][Full Text] [Related]
19. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ABCA1 protein degradation promotes HDL cholesterol efflux capacity and RCT and reduces atherosclerosis in mice.
Huang L; Fan B; Ma A; Shaul PW; Zhu H
J Lipid Res; 2015 May; 56(5):986-97. PubMed ID: 25761370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
